Cidara Therapeutics, Inc. (CDTX)
219.60
-0.69
(-0.31%)
USD |
NASDAQ |
Dec 10, 16:00
219.50
-0.10
(-0.05%)
After-Hours: 07:25
Cidara Therapeutics Free Cash Flow: -132.94M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 13.05B |
| Bristol Myers Squibb Co. | 15.30B |
| Johnson & Johnson | 20.46B |
| Mersana Therapeutics, Inc. | -74.37M |
| Pfizer Inc. | 10.38B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -40.62M |
| Cash from Investing (Quarterly) | -176.47M |
| Cash from Financing (Quarterly) | 0.16M |
| Free Cash Flow Per Share (Quarterly) | -1.511 |
| Free Cash Flow to Equity (Quarterly) | -40.27M |
| Free Cash Flow to Firm (Quarterly) | -40.62M |
| Free Cash Flow Yield | -3.65% |